Shufan Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shufan Zhao has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Shengbin Huang
Institute of Stomatology, School and Hospital of Stomatology Wenzhou Medical University Wenzhou People's Republic of China
9 shared publications Liang Chen
Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China
4 shared publications- Bin Li
Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China
3 shared publications Jun Wang
Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China; Department of Prosthodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China
3 shared publicationsShuoMin Chen
Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China
3 shared publicationsWanhang Li
Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Lucheng District, Wenzhou, People’s Republic of China
3 shared publications
Latest Publications
- Open Access
- 24 August 2026
- Published by Springer Nature in BMC Oral Health
Systemic and local oxidative stress biomarkers in periodontitis: an updated systematic review and meta-analysis
- 24 August 2026
- Published by Springer Nature in BMC Oral Health
Open AccessSystemic and local oxidative stress biomarkers in periodontitis: an updated systematic review and meta-analysis
- Open Access
- 28 March 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (4) , 426
Synthetic Novel Flavonoids SZQ-4 Suppress Osteoclastogenesis and Ameliorate Osteoporosis via Inhibiting Reactive Oxygen Species and Regulating SIRT3
The global prevalence of osteoporosis is rising, particularly among the elderly and post-menopausal population. Although natural flavonoids can inhibit osteoclast overactivation, their low abundance and extraction challenges limit clinical translation. In this study, we synthesized a flavonoid derivative, SZQ-4, and evaluated its therapeutic potential for post-menopausal osteoporosis (PMO). Using an RANKL-induced osteoclastogenesis model in vitro, we demonstrated through TRAP staining, RT-qPCR, and bone resorption assays that SZQ-4 significantly suppresses osteoclast formation and activity. Mechanistically, RNA-seq, Western blot, siRNA knockdown, and plasmid-based overexpression experiments revealed that SZQ-4 reduces RANKL-induced reactive oxygen species (ROS) production, regulates SIRT3 expression, and improves mitochondrial function, thereby attenuating osteoclast differentiation. In an ovariectomy-induced bone loss mouse model, SZQ-4 treatment markedly alleviated femoral bone loss, decreased osteoclast numbers, and lowered ROS levels in the bone marrow microenvironment. Collectively, our findings indicate that SZQ-4 inhibits osteoclast-driven bone resorption by modulating the ROS-SIRT3–mitochondrial function axis, highlighting its potential as a candidate for preventing pathological bone loss.
- 28 March 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (4) , 426
Open AccessSynthetic Novel Flavonoids SZQ-4 Suppress Osteoclastogenesis and Ameliorate Osteoporosis via Inhibiting Reactive Oxygen Species and Regulating SIRT3
The global prevalence of osteoporosis is rising, particularly among the elderly and post-menopausal population. Although natural flavonoids can inhibit osteoclast overactivation, their low abundance and extraction challenges limit clinical translation. In this study, we synthesized a flavonoid derivative, SZQ-4, and evaluated its therapeutic potential for post-menopausal osteoporosis (PMO). Using an RANKL-induced osteoclastogenesis model in vitro, we demonstrated through TRAP staining, RT-qPCR, and bone resorption assays that SZQ-4 significantly suppresses osteoclast formation and activity. Mechanistically, RNA-seq, Western blot, siRNA knockdown, and plasmid-based overexpression experiments revealed that SZQ-4 reduces RANKL-induced reactive oxygen species (ROS) production, regulates SIRT3 expression, and improves mitochondrial function, thereby attenuating osteoclast differentiation. In an ovariectomy-induced bone loss mouse model, SZQ-4 treatment markedly alleviated femoral bone loss, decreased osteoclast numbers, and lowered ROS levels in the bone marrow microenvironment. Collectively, our findings indicate that SZQ-4 inhibits osteoclast-driven bone resorption by modulating the ROS-SIRT3–mitochondrial function axis, highlighting its potential as a candidate for preventing pathological bone loss.
- Open Access
- 14 March 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103029
Procyanidin capsules attenuate PI3K/AKT-mediated mitochondrial dysfunction and accelerate skin wound healing in diabetic mice
- 14 March 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103029
Open AccessProcyanidin capsules attenuate PI3K/AKT-mediated mitochondrial dysfunction and accelerate skin wound healing in diabetic mice
- Open Access
- 16 December 2025
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 37 (6) , e581-e585
Efficacy and Safety of Different Doses of Midazolam Oral Solution for Cleft lip and Palate Repair in Children: A Randomized Controlled Study
This study aimed to compare the efficacy and safety of midazolam oral solution in children undergoing cleft lip and palate repair surgery. Children aged 4 months to 14 years old were randomly assigned to 3 groups: group A, group B, and group C. Group A received 0.3 mg/kg midazolam oral solution, group B received 0.5 mg/kg midazolam oral solution, and group C received normal saline 30 min before entering the operating room. The Ramsay Sedation Score (RSS), Mask Acceptance Score (MAS), and Pediatric Anesthesia Emergence Delirium (PAED) scale at the post-anesthesia care unit (PACU) were recorded. The secondary outcomes were the postoperative side effects during the PACU stay and the perioperative hemodynamic fluctuation. Of 75 patients enrolled, 74 completed the study. Compared with group C, groups A and B demonstrated increased RSS, reduced MAS, and PAED scale scores ( P < 0.05). Compared with group A, group B exhibited lower PAED scores, longer awakening times, and PACU stays ( P < 0.05). No significant differences were observed among the 3 groups in perioperative hemodynamic fluctuation, FLACC scores, extubation times, or postoperative side effects ( P > 0.05). These findings supported that midazolam oral solution provides effective preoperative sedation in children undergoing cleft lip and palate repair, improves mask acceptance, and reduces the incidence of emergence agitation. While the 0.5 mg/kg dose provides better mask acceptance, adequate sedation, and less emergence agitation than 0.3 mg/kg dose, it also requires a slightly longer recovery time and duration of staying PACU.
- 16 December 2025
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 37 (6) , e581-e585
Open AccessEfficacy and Safety of Different Doses of Midazolam Oral Solution for Cleft lip and Palate Repair in Children: A Randomized Controlled Study
This study aimed to compare the efficacy and safety of midazolam oral solution in children undergoing cleft lip and palate repair surgery. Children aged 4 months to 14 years old were randomly assigned to 3 groups: group A, group B, and group C. Group A received 0.3 mg/kg midazolam oral solution, group B received 0.5 mg/kg midazolam oral solution, and group C received normal saline 30 min before entering the operating room. The Ramsay Sedation Score (RSS), Mask Acceptance Score (MAS), and Pediatric Anesthesia Emergence Delirium (PAED) scale at the post-anesthesia care unit (PACU) were recorded. The secondary outcomes were the postoperative side effects during the PACU stay and the perioperative hemodynamic fluctuation. Of 75 patients enrolled, 74 completed the study. Compared with group C, groups A and B demonstrated increased RSS, reduced MAS, and PAED scale scores ( P < 0.05). Compared with group A, group B exhibited lower PAED scores, longer awakening times, and PACU stays ( P < 0.05). No significant differences were observed among the 3 groups in perioperative hemodynamic fluctuation, FLACC scores, extubation times, or postoperative side effects ( P > 0.05). These findings supported that midazolam oral solution provides effective preoperative sedation in children undergoing cleft lip and palate repair, improves mask acceptance, and reduces the incidence of emergence agitation. While the 0.5 mg/kg dose provides better mask acceptance, adequate sedation, and less emergence agitation than 0.3 mg/kg dose, it also requires a slightly longer recovery time and duration of staying PACU.
- Open Access
- 2 September 2025
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 13, 1646629
Biomaterials strategy for promoting palatal wound healing
Palatal wounds arising from trauma, tumors, cleft palate, or free gingival grafting (FGG) and other etiologies compromise critical orofacial functions including mastication, deglutition phonation and articulation, while posing life-threatening risks in severe conditions. Although surgical resection remains the primary clinical intervention, current treatment strategies for palatal injuries are constrained by several limitations, including: bacterial contamination and chronic inflammation, extensive soft tissue defects, postoperative scar formation, compromised blood supply in the surgical field, and potential patient comorbidities. Research on wound healing based on biomaterials has advanced substantially in recent decades, significantly facilitating their application in tissue engineering. This review provides a comprehensive overview of biomaterials used in palatal wounds, including acellular dermal matrix (ADM), platelet-rich derivatives (e.g., PRF, PRP), amniotic membrane, growth factor, hyaluronic acid, collagen, novel hydrogel, nanofiber scaffolds and other relevant materials. It further discusses potential mechanisms that may be involved in palatal wound healing. The objectives of this review are to summarize recent advances in preclinical and clinical studies on biomaterials for palatal wound healing and to highlight their therapeutic potential in this context.
- 2 September 2025
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 13, 1646629
Open AccessBiomaterials strategy for promoting palatal wound healing
Palatal wounds arising from trauma, tumors, cleft palate, or free gingival grafting (FGG) and other etiologies compromise critical orofacial functions including mastication, deglutition phonation and articulation, while posing life-threatening risks in severe conditions. Although surgical resection remains the primary clinical intervention, current treatment strategies for palatal injuries are constrained by several limitations, including: bacterial contamination and chronic inflammation, extensive soft tissue defects, postoperative scar formation, compromised blood supply in the surgical field, and potential patient comorbidities. Research on wound healing based on biomaterials has advanced substantially in recent decades, significantly facilitating their application in tissue engineering. This review provides a comprehensive overview of biomaterials used in palatal wounds, including acellular dermal matrix (ADM), platelet-rich derivatives (e.g., PRF, PRP), amniotic membrane, growth factor, hyaluronic acid, collagen, novel hydrogel, nanofiber scaffolds and other relevant materials. It further discusses potential mechanisms that may be involved in palatal wound healing. The objectives of this review are to summarize recent advances in preclinical and clinical studies on biomaterials for palatal wound healing and to highlight their therapeutic potential in this context.
- Open Access
- 13 August 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1623933
The novel organoselenium compound 4aa ameliorates osteoporosis by modulating gut microbiota composition and fecal metabolite profiles
Background: The gut microbiota plays a key role in regulating bone homeostasis. Our previous work demonstrated that the novel organic selenium compound β-trifluoroethoxy dimethyl selenide (4aa alleviates osteoporosis; however, its mechanism remains unclear.Method: The cytotoxicity of 4aa in osteoblast (MC3T3-E1) and osteoclast precursor (RAW264.7) cells was evaluated using CCK-8 assays. Ovariectomized (OVX) and sham-operated mice were treated with various concentrations of 4aa for 8 weeks, including a subgroup pretreated with antibiotics (ABX) to deplete the gut microbiota. Femoral bone structure was assessed by micro-computed tomography (micro-CT), osteoclast numbers were quantified, gut microbial composition was analyzed via 16S rRNA sequencing, and fecal metabolites were profiled using LC-MS/MS.Results: 4aa concentrations below 20 μM were non-cytotoxic to MC3T3-E1 and RAW264.7 cells. In vivo, 4aa significantly improved femoral bone mass and trabecular microarchitecture in OVX mice. Gut microbiota analysis revealed increased relative abundances of Dubosiella, Akkermansia, and Bacillus spp following 4aa administration. Metabolomic profiling identified marked alterations in citronellal, tyrosol, kaempferol, leukotriene D4, clomipramine, and phenol sulfate level. Moreover, 4aa elevated butyric acid levels and reduced the accumulation of α-ketoisovaleric acid (α-KIV), contributing to the inhibition of osteoclast differentiation.Conclusion: 4aa prevents estrogen deficiency-induced bone loss by modulating gut microbial composition and function. These findings support the therapeutic of 4aa as a microbiota-targeted therapeutic strategy for osteoporosis management.
- 13 August 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1623933
Open AccessThe novel organoselenium compound 4aa ameliorates osteoporosis by modulating gut microbiota composition and fecal metabolite profiles
Background: The gut microbiota plays a key role in regulating bone homeostasis. Our previous work demonstrated that the novel organic selenium compound β-trifluoroethoxy dimethyl selenide (4aa alleviates osteoporosis; however, its mechanism remains unclear.Method: The cytotoxicity of 4aa in osteoblast (MC3T3-E1) and osteoclast precursor (RAW264.7) cells was evaluated using CCK-8 assays. Ovariectomized (OVX) and sham-operated mice were treated with various concentrations of 4aa for 8 weeks, including a subgroup pretreated with antibiotics (ABX) to deplete the gut microbiota. Femoral bone structure was assessed by micro-computed tomography (micro-CT), osteoclast numbers were quantified, gut microbial composition was analyzed via 16S rRNA sequencing, and fecal metabolites were profiled using LC-MS/MS.Results: 4aa concentrations below 20 μM were non-cytotoxic to MC3T3-E1 and RAW264.7 cells. In vivo, 4aa significantly improved femoral bone mass and trabecular microarchitecture in OVX mice. Gut microbiota analysis revealed increased relative abundances of Dubosiella, Akkermansia, and Bacillus spp following 4aa administration. Metabolomic profiling identified marked alterations in citronellal, tyrosol, kaempferol, leukotriene D4, clomipramine, and phenol sulfate level. Moreover, 4aa elevated butyric acid levels and reduced the accumulation of α-ketoisovaleric acid (α-KIV), contributing to the inhibition of osteoclast differentiation.Conclusion: 4aa prevents estrogen deficiency-induced bone loss by modulating gut microbial composition and function. These findings support the therapeutic of 4aa as a microbiota-targeted therapeutic strategy for osteoporosis management.
- Top Cited PapersOpen Access
- 17 April 2025
- Published by Springer Nature in International Journal of Oral Science
- Vol. 17 (1) , 1-14
Dimethyl fumarate modulates M1/M2 macrophage polarization to ameliorate periodontal destruction by increasing TUFM-mediated mitophagy
Periodontitis is a common oral disease characterized by progressive alveolar bone resorption and inflammation of the periodontal tissues. Dimethyl fumarate (DMF) has been used in the treatment of various immune-inflammatory diseases due to its excellent anti-inflammatory and antioxidant functions. Here, we investigated for the first time the therapeutic effect of DMF on periodontitis. In vivo studies showed that DMF significantly inhibited periodontal destruction, enhanced mitophagy, and decreased the M1/M2 macrophage ratio. In vitro studies showed that DMF inhibited macrophage polarization toward M1 macrophages and promoted polarization toward M2 macrophages, with improved mitochondrial function, inhibited oxidative stress, and increased mitophagy in RAW 264.7 cells. Furthermore, DMF increased intracellular mitochondrial Tu translation elongation factor (TUFM) levels to maintain mitochondrial homeostasis, promoted mitophagy, and modulated macrophage polarization, whereas TUFM knockdown decreased the protective effect of DMF. Finally, mechanistic studies showed that DMF increased intracellular TUFM levels by protecting TUFM from degradation via the ubiquitin-proteasomal degradation pathway. Our results demonstrate for the first time that DMF protects mitochondrial function and inhibits oxidative stress through TUFM-mediated mitophagy in macrophages, resulting in a shift in the balance of macrophage polarization, thereby attenuating periodontitis. Importantly, this study provides new insights into the prevention of periodontitis.
- 17 April 2025
- Published by Springer Nature in International Journal of Oral Science
- Vol. 17 (1) , 1-14
Top Cited PapersOpen AccessDimethyl fumarate modulates M1/M2 macrophage polarization to ameliorate periodontal destruction by increasing TUFM-mediated mitophagy
Periodontitis is a common oral disease characterized by progressive alveolar bone resorption and inflammation of the periodontal tissues. Dimethyl fumarate (DMF) has been used in the treatment of various immune-inflammatory diseases due to its excellent anti-inflammatory and antioxidant functions. Here, we investigated for the first time the therapeutic effect of DMF on periodontitis. In vivo studies showed that DMF significantly inhibited periodontal destruction, enhanced mitophagy, and decreased the M1/M2 macrophage ratio. In vitro studies showed that DMF inhibited macrophage polarization toward M1 macrophages and promoted polarization toward M2 macrophages, with improved mitochondrial function, inhibited oxidative stress, and increased mitophagy in RAW 264.7 cells. Furthermore, DMF increased intracellular mitochondrial Tu translation elongation factor (TUFM) levels to maintain mitochondrial homeostasis, promoted mitophagy, and modulated macrophage polarization, whereas TUFM knockdown decreased the protective effect of DMF. Finally, mechanistic studies showed that DMF increased intracellular TUFM levels by protecting TUFM from degradation via the ubiquitin-proteasomal degradation pathway. Our results demonstrate for the first time that DMF protects mitochondrial function and inhibits oxidative stress through TUFM-mediated mitophagy in macrophages, resulting in a shift in the balance of macrophage polarization, thereby attenuating periodontitis. Importantly, this study provides new insights into the prevention of periodontitis.
- 26 April 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 146, 105026
The role of oxidative stress biomarkers in the development of peri-implant disease: A systematic review and meta-analysis
- 26 April 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 146, 105026
The role of oxidative stress biomarkers in the development of peri-implant disease: A systematic review and meta-analysis
- Open Access
- 8 December 2023
- Published by Springer Nature in BMC Oral Health
- Vol. 23 (1) , 1-11
The effect of periapical bone defects on stress distribution in teeth with periapical periodontitis: a finite element analysis
Background: Apical periodontitis directly affects the stress state of the affected tooth owing to the destruction of the periapical bone. Understanding the mechanical of periapical bone defects/tooth is clinically meaningful. In this study, we evaluate the effect of periapical bone defects on the stress distribution in teeth with periapical periodontitis using finite element analysis. Methods: Finite element models of normal mandibular second premolars and those with periapical bone defects (spherical defects with diameters of 5, 10, 15, and 20 mm) were created using a digital model design software. The edges of the mandible were fixed and the masticatory cycle was simplified as oblique loading (a 400 N force loaded obliquely at 45° to the long axis of the tooth body) to simulate the tooth stress state in occlusion and analyze the von Mises stress distribution and tooth displacement distribution in each model. Results: Overall analysis of the models: Compared to that in the normal model, the maximum von Mises stresses in all the different periapical bone defect size models were slightly lower. In contrast, the maximum tooth displacement in the periapical bone defect model increased as the size of the periapical bone defect increased (2.11–120.1% of increase). Internal analysis of tooth: As the size of the periapical bone defect increased, the maximum von Mises stress in the coronal cervix of the tooth gradually increased (2.23–37.22% of increase). while the von Mises stress in the root apical region of the tooth showed a decreasing trend (41.48–99.70% of decrease). The maximum tooth displacement in all parts of the tooth showed an increasing trend as the size of the periapical bone defect increased. Conclusions: The presence of periapical bone defects was found to significantly affect the biomechanical response of the tooth, the effects of which became more pronounced as the size of the bone defect increased.
- 8 December 2023
- Published by Springer Nature in BMC Oral Health
- Vol. 23 (1) , 1-11
Open AccessThe effect of periapical bone defects on stress distribution in teeth with periapical periodontitis: a finite element analysis
Background: Apical periodontitis directly affects the stress state of the affected tooth owing to the destruction of the periapical bone. Understanding the mechanical of periapical bone defects/tooth is clinically meaningful. In this study, we evaluate the effect of periapical bone defects on the stress distribution in teeth with periapical periodontitis using finite element analysis. Methods: Finite element models of normal mandibular second premolars and those with periapical bone defects (spherical defects with diameters of 5, 10, 15, and 20 mm) were created using a digital model design software. The edges of the mandible were fixed and the masticatory cycle was simplified as oblique loading (a 400 N force loaded obliquely at 45° to the long axis of the tooth body) to simulate the tooth stress state in occlusion and analyze the von Mises stress distribution and tooth displacement distribution in each model. Results: Overall analysis of the models: Compared to that in the normal model, the maximum von Mises stresses in all the different periapical bone defect size models were slightly lower. In contrast, the maximum tooth displacement in the periapical bone defect model increased as the size of the periapical bone defect increased (2.11–120.1% of increase). Internal analysis of tooth: As the size of the periapical bone defect increased, the maximum von Mises stress in the coronal cervix of the tooth gradually increased (2.23–37.22% of increase). while the von Mises stress in the root apical region of the tooth showed a decreasing trend (41.48–99.70% of decrease). The maximum tooth displacement in all parts of the tooth showed an increasing trend as the size of the periapical bone defect increased. Conclusions: The presence of periapical bone defects was found to significantly affect the biomechanical response of the tooth, the effects of which became more pronounced as the size of the bone defect increased.